Sharemaestro Newsreel

Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...

Nephros Inc (NEPH) reported record quarterly revenue of $6 million in Q2 2026, a 36% year-over-year increase, along with a significant surge in net income (over 400%) and Adjusted EBITDA (260%). The growth was attributed to broad-based improvements across product and service revenues, and …

BLFS SWOT Analysis: Strong Revenue Growth Amidst Strategic Changes Revealed in 10-Q Filing

Pulse Biosciences Inc (PLSE) (Q2 2026) Earnings Call Highlights: Accelerated Enrollment and ...

Pulse Biosciences Inc (PLSE) reported accelerated enrollment in its NanoPulse-AF IDE study, reaching the halfway point ahead of schedule, with strong feasibility data presented at HRS. The company strengthened its balance sheet by raising $57.5 million, extending its financial runway, and is progressing multiple …

Kestra Medical Technologies general counsel sells $86,073 in shares By Investing.com

Kestra Medical Technologies' General Counsel, Traci S. Umberger, sold 3,580 common shares worth $86,073 to cover tax obligations from vested restricted stock units. Following this transaction, she still directly holds 195,825 shares. The company's stock has seen a significant increase, though InvestingPro analysis suggests …

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

Resmed Inc. (NYSE: RMD, ASX: RMD) announced strong results for its fourth quarter and full fiscal year 2026, with Q4 revenue up 9% to a record $1.5 billion and non-GAAP diluted earnings per share increasing 16% to $2.95. The company returned $1.0 billion to …

Earnings call transcript: Nephros posts Q2 2026 growth, shares rise premarket

Nephros reported record revenue growth and stronger profitability in Q2 2026, with shares rising premarket despite a slight revenue miss. The company highlighted a 36% increase in revenue to $6.0 million and a significant rise in service-only revenue, driven by existing customers buying more …

ResMed Fiscal Q4 Non-GAAP Earnings, Revenue Up

ResMed reported increased non-GAAP earnings and revenue for its fiscal fourth quarter. The company's financial performance demonstrates growth during this period.

Earnings call transcript: Pulse Biosciences misses Q2 2026 estimates but gains on trial progress

Pulse Biosciences reported a wider-than-expected Q2 2026 loss and lower revenue but saw its stock rise after hours due to accelerated enrollment in its atrial fibrillation trial, a stronger cash position, and progress in its thyroid and surgical programs. The company's nanosecond pulsed field …

Harvard Bioscience Inc (HBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Harvard Bioscience Inc (HBIO) has an earnings forecast score of 7.00, ranking 153rd in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $2.00 with a "Buy" rating based on 2 analysts. The company's expected revenue for the next …

DENTSPLY SIRONA Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:XRAY) 2026-08-06

DENTSPLY SIRONA (NASDAQ:XRAY) announced its quarterly earnings, reporting an adjusted EPS of $0.52, beating consensus estimates of $0.35, with revenue of $898 million, slightly above expectations. Despite this beat, revenue declined 4.1% year-over-year, and the company maintained its 2026 guidance, anticipating sequential declines in …

ResMed Introduced Guidance at Request of Investors, CEO Says

ResMed's CEO, Mick Farrell, explained that the company reintroduced financial guidance due to investor requests for more transparency regarding its growth prospects and market leadership. The decision comes after the company had previously paused guidance during the COVID-19 pandemic. This move aims to provide …

Kestra Medical Technologies (NASDAQ:KMTS) CFO Vaseem Mahboob Sells 6,995 Shares

Kestra Medical Technologies CFO Vaseem Mahboob sold 6,995 shares of KMTS stock for approximately $172,637 to cover tax withholding obligations from vested equity awards, reducing his direct ownership by 7.45%. This sale follows three other recent transactions by Mahboob. The company reported a quarterly …

Alfred Ford Jr Sells 6,275 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock

Alfred Ford Jr., an insider at Kestra Medical Technologies (NASDAQ:KMTS), sold 6,275 shares for approximately $151,165 to cover tax withholding obligations. This sale reduced his direct ownership by 5.93% to 99,564 shares. Kestra Medical Technologies recently traded at $25.27, while analysts hold a "Hold" …

ResMed Inc. 2026 Q4 - Results - Earnings Call Presentation (NYSE:RMD) 2026-08-06

ResMed Inc. reported strong Q4 FY2026 results with a 9% headline revenue growth and a 16% increase in non-GAAP EPS, achieving 10% revenue growth and $1.6 billion in free cash flow for the full fiscal year. The company plans to return over $1.85 billion …

ICU Medical Q2 2026 Earnings: Organic Growth Supports Higher Guidance

ICU Medical (Nasdaq: ICUI) reported Q2 2026 revenue of $551.7 million, a 1% increase year-over-year, with organic revenue up 6% excluding divestitures and currency effects. The company saw strong performance in Infusion Systems and Consumables, while Vital Care continued to decline. Consequently, ICU Medical …

Envista (NVST) Stock Slips Despite Sharper Margins And Strong Cash Flow

KORU Medical Systems Inc (KRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and First ...

KORU Medical Systems Inc (KRMD) reported record quarterly revenue of $12 million, an 18% increase year-over-year, and achieved positive net income for the first time since 2019. Despite this, the company narrowed its full-year revenue guidance due to slower-than-expected growth in international pre-filled syringe …

Baxter International Inc. (BAX) Stock Forecasts

This article provides a Morningstar analyst report on Baxter International Inc. (BAX), detailing its 2026 outlook, revenue growth, and tariff refund impact. The report, authored by senior analyst Julie Utterback, assigns a rating and fair value to BAX, describing the company's offerings in medical …

ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance

ICU Medical, Inc. announced its financial results for the second quarter of 2026, reporting GAAP revenue growth of 1% year-over-year, and a non-GAAP organic revenue increase of 6% excluding the impact of a divestiture and foreign currency. The company also updated its fiscal year …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC

Pomerantz LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who suffered losses. The lawsuit alleges securities fraud after Embecta missed its Q2 2026 guidance and lowered its fiscal year guidance, primarily due to weak pen needle …

Zentek Ltd (ZTEK) Stock News Today

This article provides the latest stock news for Zentek Ltd (ZTEK) on TradingKey. It shows the current stock price, market capitalization, and a general overview of the company's financial information and news. The content indicates that more news will be coming soon for Zentek …

Precision Optics Corporation Inc (POCI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Precision Optics Corporation Inc (POCI), noting its current earnings forecast score of 8.00 and ranking it 65th in the Healthcare Equipment & Supplies industry. Based on one analyst, the stock has a "Buy" rating with an 89.57% …

Arrowstreet Capital Limited Partnership Buys New Position in Azenta, Inc. $AZTA

Arrowstreet Capital Limited Partnership has acquired a new position in Azenta, Inc. (NASDAQ:AZTA), purchasing 71,410 shares valued at approximately $1.51 million, representing about 0.15% of the company. This comes as Azenta reported strong quarterly earnings, exceeding analyst estimates for both EPS and revenue, though …

ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say

ICU Medical (ICUI) reported its Q2 2026 earnings, with revenues of $547.88 million, an increase of 0.8% year-over-year, and EPS of $2.37, up from $2.10 in the prior year. Both revenue and EPS surpassed Zacks Consensus Estimates by 2.33% and 24.08% respectively. Key metrics …

AptarGroup Inc (ATR) Segment President Marc Prieur Sells 3,500 S

Marc Prieur, Segment President of AptarGroup Inc (ATR), sold 3,500 shares of the company on August 4, 2026, totaling approximately $476,910. This sale contributes to a pattern of insider selling over the past year, with 12 insider sells and no buys. Despite the insider …

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU MEDICAL ($ICUI) Releases Q2 2026 Earnings, Stock Rises

Teleflex Incorporated Announces Quarterly Dividend of $0.34 (NYSE:TFX)

Teleflex Incorporated (NYSE:TFX) announced a quarterly dividend of $0.34 per share, payable on September 30th to shareholders of record on August 14th. This represents an annualized dividend of $1.36, yielding 1.0%, and is well-covered by earnings with a payout ratio of 9.7%. The medical …

Kestra Medical (KMTS) CFO plans and tax sales total 6,995 shares

Kestra Medical Technologies' CFO, Mahboob Vaseem, sold a total of 6,995 common shares on August 4, 2026. This included a nondiscretionary sell-to-cover transaction for 3,080 shares to satisfy tax withholding obligations at a weighted average price of $24.057, and a separate sale of 3,915 …

Kestra Medical (NASDAQ: KMTS) executive sells 3,580 shares for tax withholding

Traci S. Umberger, General Counsel and Chief Administrative Officer of Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), sold 3,580 common shares on August 4, 2026. This non-discretionary sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units. Following the …

Earnings call transcript: Teleflex beats Q2 2026 EPS, but shares slip premarket

Pulse Biosciences earnings missed by $0.08, revenue fell short of estimates

Dentsply Sirona Q2 2026 Earnings: Sales Decline as GAAP Margins Recover

Dentsply Sirona reported a Q2 2026 net sales decline of 4.1% to $898 million, though GAAP diluted EPS improved to $0.18 from a prior-year loss, largely due to the absence of impairment charges. While GAAP gross margins and operating cash flow increased significantly, constant-currency …

Utah Medical Products Inc (UTMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article from TradingKey provides an earnings forecast for Utah Medical Products Inc (UTMD), focusing on future EPS and revenue growth estimates. It includes a snapshot of the company's current stock performance, market capitalization, and P/E ratio, alongside a list of peer companies for …

ResMed (NYSE:RMD) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops

Align Technology Inc (ALGN) Stock Down 3.2% -- Now Undervalued? GF Score: 89/100

Align Technology Inc (ALGN) shares recently dropped by 3.2%, bringing its current price to $169.08. Despite this, the stock is considered undervalued with a GF Value™ estimate of $228.51, and boasts a strong GF Score™ of 89/100, indicating robust fundamentals. While profitability and valuation …